Navigation Links
BioSpecifics Technologies Corp. Announces Board Authorization of up to $2 Million Stock Repurchase Program
Date:12/12/2013

harmaceuticals Ltd. has the marketing rights for XIAFLEX for the treatment of Dupuytren's contracture in Canada and Australia, and Swedish Orphan Biovitrum AB markets CCH as XIAPEX® (the EU tradename for CCH) for the treatment of Dupuytren's contracture in 71 Eurasian and African countries. In December 2013, the U.S. Food & Drug Administration (FDA) approved XIAFLEX for the treatment of Peyronie's disease in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy. CCH is in clinical development for the treatment of several additional promising indications. Auxilium is testing CCH for frozen shoulder syndrome and expects to initiate next stage trials in the fourth quarter of 2013. Auxilium is also testing CCH as a treatment for cellulite in a Phase 2a study. BioSpecifics is currently managing the development of CCH for the treatment of human and canine lipomas, both of which are in Phase 2 trials, and expects to report top-line data from these trials in the fourth quarter of 2013. For more information, please visit www.biospecifics.com.

Forward Looking Statements
This release includes "forward-looking statements" within the meaning of, and made pursuant to the safe harbor provisions of, the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are "forward-looking statements." The forward-looking statements include statements concerning, among other things, the repurchasing by BioSpecifics of its common stock and the confidence that BioSpecifics has in achieving its goals; the timing for Auxilium to initiate next stage trials of CCH for frozen shoulder syndrome; and the timing for BioSpecifics' reporting top-line data from tis human and canine lipoma trials. In some cases, these statements can be identified by forward-looking words such as "b
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioSpecifics Technologies Corp. Reports Third Quarter 2013 Financial Results
2. BioSpecifics Technologies Corp. to Present at the Aegis Capital 2013 Healthcare Conference
3. BioSpecifics Technologies Corp. to Present at the Stifel Nicolaus 2013 Healthcare Conference
4. BioSpecifics Technologies Corp. Reports Second Quarter 2013 Financial Results
5. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2013 Financial Results on Thursday, August 8, 2013
6. BioSpecifics Technologies Corp. to Present at Jefferies 2013 Global Healthcare Conference
7. BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2013 Financial Results on Friday, May 10, 2013
8. BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2012 Financial Results
9. BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2012 Financial Results on Tuesday, March 12, 2013
10. BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences
11. BioSpecifics Technologies Corp. to Webcast, Live, at RetailInvestorConferences.com on December 6th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- TWi Pharmaceuticals, Inc. (4180.TT) today announced that it ... Food and Drug Administration (FDA) on its Abbreviated ... oral suspension, the generic equivalent to Par Pharmaceutical,s ... Hatch Waxman rules, it will be entitled to ... the pre-launch preparation of the generic drug.  However, ...
(Date:8/27/2014)... About 8 million Americans have peripheral arterial ... fatty plaque in the arteries, according to recent statistics. ... in incidences of diabetes and obesity, the Society ... Arterial RevascularizatioN (LEARN) meeting, Oct. 9–11 in ... residents and fellows will be able to gain state-of-the-art ...
(Date:8/27/2014)... --  Los Angeles orthodontics expert, Dr. Isaac ... want to make their treatment even faster. With this ... patients have a powerful tool to use as they ... by most patients with all types of braces, letting ... AcceleDent® Aura system for a few minutes each day. ...
Breaking Medicine Technology:TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension 2LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Los Angeles Orthodontist, Dr. Isaac Hakim, is Now Offering AcceleDent Aura 2
... 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") ... in-vitro diagnostic ("IVD") company, today announced that Chengxuan, a ... Chairman and Chief Executive Officer of the Company, informed ... American Depositary Shares ("ADSs") in the open market on ...
... of Disabled Adults and Children (FODAC) has partnered with Invacare ... of equipment and supplies to Joplin, Missouri. A massive F5 ... 2011, leaving much of the city in ruins. FODAC, with ... supply shipment to Joplin within 24 hours of the disaster. ...
Cached Medicine Technology:China Medical Technologies Announces the Purchase of its ADSs by Chengxuan in the Open Market 2Friends of Disabled Adults and Children Partners With Invacare to Provide Aid in Wake of Joplin Tornado 2Friends of Disabled Adults and Children Partners With Invacare to Provide Aid in Wake of Joplin Tornado 3
(Date:8/27/2014)... 2014 DiaSorin has announced that their ... Dihydroxyvitamin D,” will feature guest speaker Dr. Gregory A. ... for Health and Healing Integrative Medicine. Dr. Plotnikoff serves ... Institute for Health and Healing and as Senior Consultant, ... Minnesota. He also serves as a co-editor of the ...
(Date:8/27/2014)... Recently, Skmen.com, a renowned garment manufacturer and ... bodycon dresses . The company has rich experience in ... items in stock and ready to ship: celebrity bodycon ... sweater dresses and so forth. All of them are ... “We are proud to announce the new collection of ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Taking its popular ... Steele Creek YMCA will host its largest crowd ... on Saturday, September 13 at YMCA Camp Thunderbird . ... race divisions: adult, youth and teams. Within each division, ... to their physical limit - for a worthy cause. ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Today, Zane ... webinar on compliance tips for administering a premium reimbursement ... reform in full effect, compliance is top of mind ... transition to individual health insurance and premium reimbursement, there ... , In the 35 minute webinar, Zane Benefits President, ...
(Date:8/27/2014)... Skirt Sports , the innovative women’s ... pioneer runner, Kathrine Switzer, most noted for her brave running ... a line of women’s running clothes that unites the history ... 261 Fearless Movement. , “It is such an ... DeBoom. “Kathrine is the original Skirt – she stood ...
Breaking Medicine News(10 mins):Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 2Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 3Health News:Skmen.com Unveils Its New Celebrity Bodycon Dresses for Its Loyal Customers 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:Zane Benefits Announces Upcoming Webinar on Compliance 2Health News:Skirt Sports Launches Clothing Line with Legendary Runner Kathrine Switzer 2
... ... through its ActiveBase Security™ solution, today announced it has been included in the list of ... Joseph Feiman, Neil MacDonald, John Pescatore, Earl Perkins April 14, 2010, by Gartner Inc. ... Tel Aviv, Israel (PRWEB) April ...
... cases stem from established risk factors, study finds, , ... to increase the odds of breast cancer in white women ... , For instance, for postmenopausal women in the study, "recent ... to play as big a role in Hispanics," said Dr. ...
... ... Spearhead Company,s Quality, Regulatory and Compliance Matters , ... Panama City, Fla. (PRWEB) April 26, 2010 -- ... appointment of Samuel Patton as the company’s chief quality and regulatory officer. He will ...
... ... publishes new e-book that helps people choose the right dentist to perform dental implant surgery. ... (PRWEB) April 26, ... launched her newest e-book, Dental Implants: The Five Questions You Must Ask Your ...
... ... announced a small business Internet video advertising program that can deliver first ... required for traditional web page search engine optimization. The Site Steering small ... promotional video, and using a proprietary method to distribute the video to ...
... BMJ , Nigel Hawkes, freelance journalist and Director of Straight ... investigates how the way that patients are allocated diagnostic codes ... hospital,s performance. It follows two articles published by ... rates to judge hospital performance is a bad idea. ...
Cached Medicine News:Health News:Leading Industry Analyst Firm Names ActiveBase "Cool Vendor" 2Health News:Leading Industry Analyst Firm Names ActiveBase "Cool Vendor" 3Health News:Leading Industry Analyst Firm Names ActiveBase "Cool Vendor" 4Health News:Breast Cancer Risks Not Same for Hispanic Women 2Health News:Breast Cancer Risks Not Same for Hispanic Women 3Health News:iSirona Appoints Chief Quality and Regulatory Officer to Oversee Quality Initiatives 2Health News:New E-Book Explains the Facts About Dental Implants 2Health News:Site Steering Launches Keyword Targeted Small Business Internet Video Advertising Program That Achieves First Page Search Results Within Days 2Health News:Site Steering Launches Keyword Targeted Small Business Internet Video Advertising Program That Achieves First Page Search Results Within Days 3Health News:Is patient coding making hospitals appear better than they are? 2
... Captia Borrelia burgdorferi (B. burgdorferi) IgG/IgM Enzyme ... the qualitative presumptive (firststep) detection of total ... serum. This ELISA should only be used ... are consistent with Lyme disease. Equivocal or ...
POLYSORB™ sutures are composed of LACTOMER™ glycolide/lactide copolymer which is a synthetic polyester composed of glycolide and lactide (derived from glycolic and lactic acids)....
SURGIPRO™ BLUE Monofilament Suture in two sizes....
Surgitie&trade Single Use Ligating Loops with Delivery System...
Medicine Products: